This article reviews the effectiveness of chelation therapy in treating atherosclerosis, particularly in diabetic patients who have experienced a myocardial infarction (MI). Based on findings from the Trial to Assess Chelation Therapy (TACT), the therapy was shown to reduce cardiovascular events by 41% in post-MI patients with diabetes, leading to
